Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Westermark
Giampaolo Merlini

Showing results (91-100 of 587) with videos related to

Pageof 59
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 12, 2022
Targeting Amyloid Fibrils by Passive Immunotherapy in Systemic AmyloidosisMario Nuvolone, Alice Nevone, Giampaolo Merlini
British Journal of Haematology|February 4, 2020
A powerful oral triplet for AL amyloidosisGiovanni Palladini, Paolo Milani, Giampaolo Merlini
Haematologica|November 21, 2007
Bortezomib in the treatment of AL amyloidosis: targeted therapy?Roberto Sitia, Giovanni Palladini, Giampaolo Merlini
Mediterranean Journal of Hematology and Infectious Diseases|March 14, 2018
Light Chain AmyloidosisPaolo Milani, Giampaolo Merlini, Giovanni Palladini
Clinical Chemistry and Laboratory Medicine|April 23, 2003
Guidelines for the analysis of Bence Jones proteinMariastella Graziani, Giampaolo Merlini, Concetta Petrini, et al.
Expert Review of Cardiovascular Therapy|October 27, 2015
Novel strategies for the diagnosis and treatment of cardiac amyloidosisGiovanni Palladini, Paolo Milani, Giampaolo Merlini
Expert Review of Hematology|January 9, 2018
New concepts in the treatment and diagnosis of amyloidosisPaolo Milani, Giovanni Palladini, Giampaolo Merlini
Hemasphere|January 25, 2020
Here to Stay: Biosimilars in HematologyJohn Gribben, Giampaolo Merlini, Anton Hagenbeek
Swiss Medical Weekly|December 22, 2006
Therapy and management of systemic AL (primary) amyloidosisGiovanni Palladini, Vittorio Perfetti, Giampaolo Merlini
Haematologica|July 2, 2019
Predicting survival in light chain amyloidosisGiovanni Palladini, Paolo Milani, Giampaolo Merlini
Pageof 59

Showing results (91-100 of 587) with videos related to

Sort By:
Pageof 59
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 12, 2022
Targeting Amyloid Fibrils by Passive Immunotherapy in Systemic AmyloidosisMario Nuvolone, Alice Nevone, Giampaolo Merlini
British Journal of Haematology|February 4, 2020
A powerful oral triplet for AL amyloidosisGiovanni Palladini, Paolo Milani, Giampaolo Merlini
Haematologica|November 21, 2007
Bortezomib in the treatment of AL amyloidosis: targeted therapy?Roberto Sitia, Giovanni Palladini, Giampaolo Merlini
Mediterranean Journal of Hematology and Infectious Diseases|March 14, 2018
Light Chain AmyloidosisPaolo Milani, Giampaolo Merlini, Giovanni Palladini
Clinical Chemistry and Laboratory Medicine|April 23, 2003
Guidelines for the analysis of Bence Jones proteinMariastella Graziani, Giampaolo Merlini, Concetta Petrini, et al.
Expert Review of Cardiovascular Therapy|October 27, 2015
Novel strategies for the diagnosis and treatment of cardiac amyloidosisGiovanni Palladini, Paolo Milani, Giampaolo Merlini
Expert Review of Hematology|January 9, 2018
New concepts in the treatment and diagnosis of amyloidosisPaolo Milani, Giovanni Palladini, Giampaolo Merlini
Hemasphere|January 25, 2020
Here to Stay: Biosimilars in HematologyJohn Gribben, Giampaolo Merlini, Anton Hagenbeek
Swiss Medical Weekly|December 22, 2006
Therapy and management of systemic AL (primary) amyloidosisGiovanni Palladini, Vittorio Perfetti, Giampaolo Merlini
Haematologica|July 2, 2019
Predicting survival in light chain amyloidosisGiovanni Palladini, Paolo Milani, Giampaolo Merlini
Pageof 59